Inhibitors of histone deacetylase
4 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions. One aspect of the invention provides compounds of formula (1):
in which T, A and X are as described herein.
29 Citations
33 Claims
- 1. A compound of formula (1):
-
23. A compound selected from the group consisting of:
-
(S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate; (S)-Methyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-Ethyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-tert-Butyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-Isobutyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-Benzyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-N-(1-(4-(2-Aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl)morpholine-4-carboxamide; ((S)-Pyridin-3-ylmethyl-1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-N-(2-Aminophenyl)-4-(3-(3-(pyridin-3-ylmethyl)ureido)pyrro lidin- 1 -yl) benzamide; (S)-2-Methoxyethyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (R)-2-Methoxyethyl 1-(5-(2-aminophenylcarbamoyl)pyridin-2-yl)pyrrolidin-3-yl carbamate; (S)-N-(2-Aminophenyl)-4-(3-(3-(pyridin-3-ylmethyl)thioureido)pyrrolidin- 1-yl) benzamide; (S)-O-Methyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-ylcarbamothioate; (S)-2,2,2-Trifluoroethyl 1-(4-(2-aminophenylcarbamoyl)phenyl)-pyrrolidin-3-ylcarbamate; (S)-N-(2-Aminophenyl)-4-(3-(2-(dimethylamino) acetamido) pyrrolidin-1-yl)benzamide; (S)-Pyridin-4-ylmethyl 1-(4-(2-aminophenyl carbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-Pyridin-2-ylmethyl 1-(4-(2-aminophenyl carbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-3-(Dimethyl amino)propyl 1-(4-(2-amino phenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-Furan-3-ylmethyl1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (R)-1-Methylpyrrolidin-3-yl (S)-1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl carbamate; (S)-1-(4-(2-Aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl acetate; (S)-N-(2-Aminophenyl)-4-(3-hydroxypyrrolidin-1-yl)benzamide; (S)-1-(4-(2-Aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl ethyl carbamate; (S)-O-1-(4-(2-Aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl 2-morpholinoethylcarbamothioate; (S)-N-(2-Aminophenyl)-4-(3-(dimethylamino)pyrrolidin-1-yl)benzamide; (S)-N-(2-Aminophenyl)-4-(3-(phenylmethylsulfonamido)pyrrolidin-1-yl)benzamide; (S)-2-morpholinoethyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-ylcarbamate; (S)-methyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl(pyridin-3-ylmethyl) carbamate; (S)-benzyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-yl(3,4,5-trimethoxybenzyl) carbamate; (S)-isopropyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-ylcarbamate; (S)-cyclopropylmethyl 1-(4-(2-aminophenylcarbamoyl)phenyl)pyrrolidin-3-ylcarbamate; (S)-tetrahydro-2H-pyran-4-yl 1-(4-(2-aminophenylcarb amoyl)phenyl)pyrro lidin-3-ylcarbamate, and (R)-N-(2-Aminophenyl)-4-(3-hydroxypyrro lidin-1-yl)benzamide.
-
Specification